SPOTLIGHT -
High Hopes for Inclisiran. Will the Third Time be the Charm for PCSK9 Inhibition?
The two PCSK9 inhibitors have fallen far short of expectations. Inclisiran, which works by RNA inference, only needs to be injected twice a year.
Read More
Rheumatoid Arthritis Drug Pipeline at a Trickle
DMARDs and the JAK Inhibitors have improved RA treatment. But not many new drugs are in the offing at the moment.
NASH Drug Pipeline Shows Promise
The first FDA-approved product for NASH on the horizon.
Will new autoimmune drugs address cost concerns?
Find out what’s in the drug pipeline for autoimmune disease.